A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas
Federico Mario Aletti, Jinsheng Weng, Cao Cuong Le, Jingwei Liu, Faezeh Darbaniyan, Abdur Rehman, Matthew D. Richard, Selin Kolsuz, Xiaoyun Cheng, Sridevi Patchva, Yongfu Tang, Chun-Yen Lin, JingJing Cao, Kamini Singh, Shriya D. Reddy, , Sattva S. Neelapu
This paper develops a KIR3DL2-directed CAR T-cell therapy for T-cell lymphomas, showing preclinical efficacy and safety in xenograft models.
bioRxiv · Nov 6, 2026 · PreprintImmunology